```html

Tinea Capitis: A Complete Patient‑Friendly Guide

Overview

Tinea capitis (also called scalp ringworm) is a fungal infection of the hair shaft and scalp caused primarily by dermatophyte fungi of the genera Trichophyton and Microsporum. It is contagious, spreads through direct contact or fomites (comb, pillow, hats), and is the most common cause of hair loss in children.

• Age group: 95% of cases occur in children 3–14 years old, with a peak between 5 and 9 years.
• Gender: Slight male predominance (≈1.5 : 1) in many regions.
• Geography: More prevalent in warm, humid climates and in communities with crowded living conditions. In the United States, incidence ranges from 2 to 5 cases per 1,000 children per year; in parts of Africa and South‑America rates exceed 20 per 1,000.
• Public‑health impact: The CDC reports that outbreaks in schools and daycare centers account for > 30% of all pediatric dermatophyte infections in the U.S. (2019‑2022 data).

Symptoms

Symptoms develop weeks after exposure and can vary from mild scaling to extensive alopecia. Common findings include:

• Patchy hair loss: Small, round or oval bald spots often with a “black dot” appearance where hairs have broken at the scalp level.
• Scaling and crusting: Fine, silvery or yellowish scales that may become crusty, especially around the edges of patches.
• Itching (pruritus): Varies from mild to intense; scratching can lead to secondary bacterial infection.
• Inflammatory lesions:
  • Kerion – a painful, boggy, suppurative nodule that may ooze pus.
  • Erythema and swelling – raised, red, tender areas.
• Broken hairs (hair breakage): Hairs break off close to the scalp, leaving “pencil‑thin” stubs.
• Secondary bacterial infection: Redness, warmth, and purulent drainage if the skin becomes colonised by Staphylococcus or Streptococcus.
• General symptoms (rare): Low‑grade fever, malaise, or lymphadenopathy in extensive disease.

Causes and Risk Factors

Fungal agents

The infection is caused by dermatophytes that feed on keratin. The most common species differ by region:

• Trichophyton tonsurans – predominant in North America & Europe.
• Microsporum canis – associated with contact with infected cats/dogs.
• Trichophyton violaceum and Trichophyton mentagrophytes – common in Africa & Middle East.

Risk factors

• Living in crowded or low‑socioeconomic housing.
• Close contact with infected children or pets.
• Sharing personal items (combs, hats, pillows, headphones).
• Warm, humid environments that favor fungal growth.
• Underlying skin conditions (eczema, seborrheic dermatitis) that disrupt the scalp barrier.
• Immunocompromise (e.g., HIV, chemotherapy) – increases severity, though infection is still mainly pediatric.

Diagnosis

Diagnosing tinea capitis requires a combination of clinical suspicion and laboratory confirmation.

Clinical examination

• Visual inspection of characteristic patches, “black dots,” and kerions.
• Wood’s lamp (UV) examination – bright green fluorescence suggests M. canis or M. audouinii, but many species (including T. tonsurans) are non‑fluorescent.

Laboratory tests

• KOH (potassium hydroxide) preparation: Scraping of scales or hair is placed on a slide with 10‑20% KOH. Under microscopy, branching septate hyphae confirm dermatophyte presence.
• Fungal culture: Hair or skin samples are inoculated on Sabouraud dextrose agar. Cultures take 1‑3 weeks but identify the exact species, guiding therapy.
• Polymerase chain reaction (PCR): Molecular methods provide rapid species identification; increasingly available in reference labs.
• Histopathology (rare): Skin biopsy with special stains (PAS) can be used when diagnosis is unclear.

Treatment Options

Because the infection resides deep within hair follicles, topical agents alone are insufficient. Systemic (oral) antifungal therapy is the cornerstone of treatment, supplemented by topical measures to reduce contagion.

First‑line oral antifungals

• Griseofulvin – 20–25 mg/kg/day in a single daily dose for 6–12 weeks. Effective against most dermatophytes; however, liver toxicity and drug interactions require monitoring.
• Terbinafine – 10–15 mg/kg/day (max 250 mg) for 4–6 weeks. Preferred for T. tonsurans due to higher cure rates and shorter course.
• Itraconazole – 5 mg/kg/day in two divided doses for 4–6 weeks (pulsed therapy may be used). Useful when griseofulvin is contraindicated.
• Fluconazole – 6–12 mg/kg once weekly for 6–12 weeks (off‑label). Considered when other agents are not tolerated.

All oral agents require baseline liver function tests (ALT, AST, bilirubin) and periodic monitoring, especially in children with pre‑existing liver disease.

Adjunctive topical therapy

• Selenium sulfide 2.5% shampoo – used 2–3 times weekly to reduce spores and limit spread.
• Ketoconazole 2% shampoo – alternative for patients with selenium sensitivity.
• Topical antifungal creams (e.g., clotrimazole) are NOT effective for the infection itself but can treat secondary bacterial infection.

Procedural interventions

• Incision & drainage of kerion: Large, painful nodules may need to be opened to relieve pressure and obtain pus for culture.
• Antibiotics: Empiric oral antibiotics (e.g., cephalexin) are indicated if a secondary bacterial infection is suspected.

Lifestyle and supportive measures

• Maintain short hair length; avoid tight braids or hair accessories that trap moisture.
• Wash bedding, hats, and combs with hot water (> 60 °C) and dry on high heat.
• Isolate affected children from group activities until they have been on oral therapy for at least 2 weeks (CDC recommendation).

Living with Tinea capitis

While the infection is treatable, the social and emotional impact—especially for children—can be significant. Below are practical tips to improve daily life.

Hair care

• Use a gentle, sulfate‑free shampoo to avoid scalp irritation.
• Apply medicated shampoo (selenium sulfide) after washing and leave on for 5 minutes before rinsing.
• Avoid sharing combs, hairbrushes, hats, or earbuds.

School & childcare

• Notify teachers and the school nurse; provide a copy of the physician’s note.
• Ask the school to implement cleaning protocols for shared items (e.g., helmets, musical instrument mouthpieces).
• Encourage the child to keep hair clean and to wash hands frequently.

Psychosocial support

• Explain the condition in age‑appropriate language; reassure the child that it is not contagious after treatment begins.
• Consider counseling if hair loss causes low self‑esteem.
• Support groups (online or community‑based) can provide peer reassurance.

Follow‑up care

• Schedule a follow‑up visit 2–4 weeks after starting oral therapy to assess response and monitor liver enzymes.
• Continue medicated shampoo for the full course, even if lesions improve.
• Document resolution of hair loss; new hair usually regrows within 2–3 months after the fungus is cleared.

Prevention

Because tinea capitis spreads easily, preventive measures are crucial, especially in households with multiple children.

• Personal hygiene: Daily hair washing with regular shampoo; keep nails trimmed to reduce scratching.
• Environmental cleaning: Wash bedding, pillowcases, towels, and hats weekly in hot water; dry on high heat.
• Pet health: If a cat or dog is suspected of having ringworm, have a veterinarian perform a fungal culture and treat the animal promptly.
• Avoid sharing: Do not share combs, brushes, hats, helmets, or headphones.
• Screening after exposure: Examine classmates or siblings for early signs; early treatment curtails spread.
• School policies: Encourage schools to have a protocol for managing dermatophyte outbreaks (CDC guidelines).

Complications

When left untreated or inadequately treated, tinea capitis can lead to:

• Permanent scarring alopecia: Fibrotic patches may persist after infection resolves.
• Kerion formation: Suppurative nodules that can ulcerate and scar.
• Secondary bacterial infection: Cellulitis or impetigo requiring systemic antibiotics.
• Psychological impact: Anxiety, bullying, or low self‑esteem due to visible hair loss.
• Spread to other body sites: Hands, nails (tinea unguium), or groin (tinea cruris) via autoinoculation.

When to Seek Emergency Care

References

• Mayo Clinic. Tinea capitis (scalp ringworm). https://www.mayoclinic.org/diseases‑conditions/tinea‑capitis
• Centers for Disease Control and Prevention. Ringworm (Dermatophytosis) – Tinea capitis. https://www.cdc.gov/fungal/diseases/ringworm/top‑facts.html
• National Institutes of Health, Office of Rare Diseases. Scalp Ringworm (Tinea Capitis). https://rarediseases.info.nih.gov/diseases/10388/tinea-capitis
• World Health Organization. Guidelines for the Management of Dermatophytoses. 2022.
• Cleveland Clinic. Scalp Ringworm (Tinea Capitis) Treatment Options. https://my.clevelandclinic.org/health/diseases/21095‑tinea‑capitis
• Gupta AK, et al. “Current Treatment of Dermatophyte Infections.” *Clinical Dermatology*, 2021.

```